ESM1 and colorectal carcinoma: Based on the established analysis algorithm, the effective candidate biomarkers ESM1, CTHRC1 and AZGP1 have been identified from the blood, urine and saliva of patients with CRC, contributing to a better understanding of the molecular mechanism of CRC and providing a theoretical basis for clinical treatment [23].